Skip to main content
Clinical Trials/NCT01869257
NCT01869257CompletedPhase 3

Impact of Triclosan-coated Suture on Surgical Site Infection After Colorectal Surgery

University of Milano Bicocca1 site in 1 country279 target enrollmentStarted: May 1, 2009Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
279
Locations
1
Primary Endpoint
Rate of surgical site infection

Study Overview

Brief Summary

Despite adequate antimicrobial prophylaxis and perioperative correction of risk factors, surgical site infections (SSI) remain the most frequent complication of colorectal resection (range 10-17%). Several strategies may be implemented to prevent SSI. Among these, the use of local antimicrobial agents seems successful.

The primary aim of the present trial was to evaluate the efficacy of a surgical suture, coated with Triclosan a synthetic soluble antimicrobial agent, in reducing the SSI rate after colorectal operations.

Detailed Description

This was a non-sponsored, multicenter, prospective, randomized, controlled, single-blind study. Two hundred and seventy-three patients candidate to colorectal resection were enrolled. Exclusion criteria were: age < 18 or > 85 years, pregnancy, peritonitis, peritoneal contamination during operation, ongoing infections, ASA score > 3, denied consent.

135 were randomized to the treatment arm and 136 to the control arm. Treatment consisted of abdominal wound closure by suturing peritoneum, fascia, subcutaneous tissue, and skin with Polyglactin 910 Triclosan-coated suture (treatment arm) or with Polyglactin without Triclosan (control arm). SSI were defined according to the Atlanta CDC. Patients were followed up by office visits for 30 days after discharge.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 85 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •patients candidate to elective colorectal resection

Exclusion Criteria

  • •no consent
  • •peritonitis
  • •hypersensitivity to triclosan
  • •ongoing infections

Arms & Interventions

control

Active Comparator

regular suture not coated with triclosan

Intervention: regular suture (Device)

triclosan

Experimental

Experimental group will receive abdominal wound closure with suture matherial that is coated with triclosan

Intervention: Triclosan coated suture (Device)

Outcomes

Primary Outcomes

Rate of surgical site infection

Time Frame: 30 days

the incidence of superficial and deep wound infection in patients who underwent colorectal resection will be determined by a blind observer according to the Atlanta CDC definition. The unit of measure will be number of wound infection over the number of treated or control patients

Secondary Outcomes

  • overall wound complications(30 days)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Luca Vittorio Gianotti

Researcher

University of Milano Bicocca

Study Sites (1)

Loading locations...

Similar Trials